These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors. Yoon JH; Hong AR; Kim HK; Kang HC Endocrinol Metab (Seoul); 2021 Apr; 36(2):413-423. PubMed ID: 33820396 [TBL] [Abstract][Full Text] [Related]
13. Nivolumab-induced Thyroid Dysfunctions in Patients with Previously Treated Non-small Cell Lung Cancer. Zhang X; Wu Y; Lv J; Li X; Ma L; Nong J; Zhang H; Qin N; Zhang Q; Shi G; Yang X; Wang J; Zhang S Interdiscip Sci; 2019 Jun; 11(2):287-291. PubMed ID: 31187431 [TBL] [Abstract][Full Text] [Related]
14. [Nivolumab-induced hypothyroidism: A case report]. Lin C; Guo Z; Mo Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 44(2):222-224. PubMed ID: 30837393 [TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitor-related thyroid dysfunction. Iwama S; Kobayashi T; Yasuda Y; Arima H Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101660. PubMed ID: 35501263 [TBL] [Abstract][Full Text] [Related]
17. Predictive Factors of Nivolumab-induced Hypothyroidism in Patients with Non-small Cell Lung Cancer. Maekura T; Naito M; Tahara M; Ikegami N; Kimura Y; Sonobe S; Kobayashi T; Tsuji T; Minomo S; Tamiya A; Atagi S In Vivo; 2017; 31(5):1035-1039. PubMed ID: 28882978 [TBL] [Abstract][Full Text] [Related]
18. Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab. Yamauchi I; Yasoda A; Matsumoto S; Sakamori Y; Kim YH; Nomura M; Otsuka A; Yamasaki T; Saito R; Kitamura M; Kitawaki T; Hishizawa M; Kawaguchi-Sakita N; Fujii T; Taura D; Sone M; Inagaki N PLoS One; 2019; 14(5):e0216954. PubMed ID: 31086392 [TBL] [Abstract][Full Text] [Related]
19. Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma. Yano S; Ashida K; Nagata H; Ohe K; Wada N; Takeichi Y; Hanada Y; Ibayashi Y; Wang L; Sakamoto S; Sakamoto R; Uchi H; Shiratsuchi M; Furue M; Nomura M; Ogawa Y BMC Endocr Disord; 2018 Jun; 18(1):36. PubMed ID: 29884162 [TBL] [Abstract][Full Text] [Related]
20. Low frequency of positive antithyroid antibodies is observed in patients with thyroid dysfunction related to immune check point inhibitors. Mazarico I; Capel I; Giménez-Palop O; Albert L; Berges I; Luchtenberg F; García Y; Fernández-Morales LA; De Pedro VJ; Caixàs A; Rigla M J Endocrinol Invest; 2019 Dec; 42(12):1443-1450. PubMed ID: 31093955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]